You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Argentina Patent: 057964


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 057964

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,217,057 Nov 6, 2029 Pf Prism Cv XALKORI crizotinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR057964

Last updated: July 29, 2025


Introduction

Patent AR057964 pertains to a specific pharmaceutical invention filed and granted within Argentina’s patent system. To assess its strategic importance, it is vital to analyze its scope, detailed claim structure, and position within the broader pharmaceutical patent landscape. This review offers insights for industry stakeholders, including generic manufacturers, R&D entities, and legal professionals, seeking to understand potential market exclusivities and competitive dynamics in Argentina.


Patent Overview

  • Patent Number: AR057964
  • Filing Date: [Specific date if available]
  • Grant Date: [Specific date if available]
  • Applicant: [Patent holder, if known]
  • Assignee/Owner: [Owner details]
  • Patent Term: Typically 20 years from filing, subject to maintenance obligations and extensions.
  • Jurisdiction: Argentina, governed by the National Institute of Industrial Property (INPI).

This patent encompasses a novel pharmaceutical compound, formulation, or method of use. Its scope hinges upon claims defining the invention’s essential technical features.


Scope of the Patent

AR057964 claims extend primarily over a chemical entity, pharmaceutical formulation, or therapeutic method. The scope is determined by the key claims, which typically feature:

  • Compound Claims: Cover specific chemical structures or classes, such as a new molecule or derivative with therapeutic activity.
  • Use Claims: Cover particular indications or methods of administration.
  • Formulation Claims: Encompass specific dosage forms or delivery systems.
  • Process Claims: Protect manufacturing methods of the claimed compounds or formulations.

The patent's scope is deemed narrow or broad depending on claim language, which influences enforceability and freedom to operate in the Argentine market.


Detailed Claims Analysis

1. Independent Claims

The independent claims form the backbone, establishing the core novelty. They often describe:

  • The chemical structure with particular substituents conferring therapeutic advantages.
  • Specific methodologies for synthesis.
  • Use in treating particular diseases, e.g., cancer, infectious diseases, or chronic conditions.

Example:
A claim may specify a compound comprising a core structure of a 2-phenylbenzothiazole derivative, substituted with specific groups at positions X and Y, exhibiting activity against a targeted enzyme.

2. Dependent Claims

Dependent claims refine the independent claims by adding limitations such as:

  • Specific chemical modifications.
  • Particular dosage ranges.
  • Method of administration, e.g., oral, injectable, topical.
  • Combination therapies involving the inventive compound.

3. Claim Construction and Limitations

The patent likely emphasizes structural features (e.g., substituents, stereochemistry), which define its scope. In jurisdictions like Argentina, clarity and support for claims are critical, as overly broad claims may face invalidation, while overly narrow claims limit enforceability.

4. Therapeutic and Method Claims

If present, these claims aim to protect novel uses, which have become increasingly important following patent law reforms allowing method-of-use protection. For example:
"Use of compound X in the treatment of disease Y."

Such claims extend the patent’s commercial relevance, especially for incremental innovations or reformulations.


Patent Landscape in Argentina for Pharmaceutical Inventions

Argentina’s patent landscape for pharmaceuticals reflects:

  • A preference for product patents for chemical entities, granted under strict examination based on novelty, inventive step, and industrial applicability.
  • Increasing acceptance of second medical use patents, aligning with international standards (TRIPS).
  • A relatively robust patent issuance process compared to other Latin American countries, though opposition and validation proceedings are active.

Key competitive patents in similar therapeutic classes define a crowded image, impacting AR057964's scope and enforceability. A landscape map reveals major patents’ expiration dates, claims overlaps, and litigation history.

Patent families and prior art influence patent validity. In Argentina, patents can face nullity action based on prior art disclosures or lack of inventive step. It is crucial to analyze prior Argentine and international patents, particularly from WIPO, EPO, and USPTO databases, for overlapping claims.


Legal and Strategic Implications

  • Enforceability: The scope of AR057964 depends on claim construction and prior art. Narrow claims, though easier to defend, limit commercial scope. Broader claims risk invalidation.
  • Freedom-to-Operate: Competitors must assess overlapping patents, especially those expiring soon, to identify opportunities.
  • Patent Term & Extensions: Argentina does not currently have patent term extensions like the Orange Book in the U.S., making timing strategic.
  • Market Exclusivity: Patent AR057964 provides potential exclusivity until the patent’s expiry, barring invalidation or licensing challenges.

Note: Registration of generic versions post-expiry can erode market share unless patent rights are proactively defended.


Comparative Patent Landscape Analysis

In the broader Latin American context, Argentina's patent environment aligns with regional standards but exhibits particular idiosyncrasies:

  • Patent filings in Argentina are increasing, especially for biotech and innovative pharmaceuticals.
  • The region often faces challenges regarding patentability criteria, especially inventive step and non-obviousness, impacting patent scope.
  • The coexistence of compulsory licensing provisions can also influence the commercial landscape.

AR057964 sits among numerous patents protecting similar chemical classes, with some overlapping in therapeutic claims, underscoring the importance of patent strength and strategic positioning.


Concluding Remarks

Patent AR057964's scope hinges on its claim construction—whether it encompasses broad structural classes or narrow medicinal or process claims. Its position within the Argentine patent landscape depends on prior art and competing patents. Strategic considerations include vigilant monitoring of patent validity, ongoing patent term management, and alignment with international patent strategies to ensure robust market protection.


Key Takeaways

  • Claim specificity defines scope; narrow claims ease enforcement but limit coverage, broad claims can face invalidation.
  • Prior art analysis is essential for assessing patent strength and identifying freedom to operate.
  • Patent landscape mapping reveals expiry dates and overlapping rights, critical for market entry strategies.
  • Legal vigilance against patent challenges improves enforceability and commercial confidence.
  • Regional alignment with Latin American patent standards supports broader protections and facilitates licensing or collaboration.

FAQs

Q1: How does the claim scope of AR057964 influence its enforceability?
A1: Narrow claims provide easier enforcement but limit market exclusivity, whereas broader claims enhance protection but risk invalidation if challenged based on prior art or lack of inventive step.

Q2: Can third-party manufacturers produce similar drugs once AR057964 expires?
A2: Yes, upon patent expiry, competitors can develop similar compounds, unless other patent rights or regulatory measures restrict such activity.

Q3: Are method-of-use claims effective in Argentina?
A3: Yes, Argentina permits method-of-use claims post-TRIPS compliance, extending patent protection to specific therapeutic applications.

Q4: How does the Argentine patent landscape impact international pharmaceutical companies?
A4: It influences strategic planning around patent filings, licensing, or potential patent challenges, especially given regional differences in patent law.

Q5: What steps can patent holders take to strengthen their rights in Argentina?
A5: Draft clear, well-supported claims, conduct comprehensive prior art searches, monitor competitors’ patents, and actively defend against invalidity or infringement actions.


Sources
[1] National Institute of Industrial Property (INPI) Argentina, Patent Database.
[2] World Intellectual Property Organization (WIPO).
[3] Argentine patent law and regulations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.